The Future of Artificial Intelligence and Machine Learning in Kidney Health and Disease.

Adv Chronic Kidney Dis

Icahn School of Medicine at Mount Sinai New York, NY; Renal Research Institute New York, NY.

Published: September 2022

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ackd.2022.09.001DOI Listing

Publication Analysis

Top Keywords

future artificial
4
artificial intelligence
4
intelligence machine
4
machine learning
4
learning kidney
4
kidney health
4
health disease
4
future
1
intelligence
1
machine
1

Similar Publications

Speech Technology for Automatic Recognition and Assessment of Dysarthric Speech: An Overview.

J Speech Lang Hear Res

January 2025

Centre for Language Studies, Radboud University, Nijmegen, the Netherlands.

Purpose: In this review article, we present an extensive overview of recent developments in the area of dysarthric speech research. One of the key objectives of speech technology research is to improve the quality of life of its users, as evidenced by the focus of current research trends on creating inclusive conversational interfaces that cater to pathological speech, out of which dysarthric speech is an important example. Applications of speech technology research for dysarthric speech demand a clear understanding of the acoustics of dysarthric speech as well as of speech technologies, including machine learning and deep neural networks for speech processing.

View Article and Find Full Text PDF

Evaluating a clinically available artificial intelligence model for intracranial aneurysm detection: a multi-reader study and algorithmic audit.

Neuroradiology

January 2025

Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China.

Purpose: We aimed to validate a clinically available artificial intelligence (AI) model to assist general radiologists in the detection of intracranial aneurysm (IA) in a multi-reader multi-case (MRMC) study, and to explore its performance in routine clinical settings.

Methods: Two distinct cohorts of head CT angiography (CTA) data were assembled to validate an AI model. Cohort 1, comprising gold-standard consecutive CTA cases, was used in an MRMC study involving six board-certified general radiologists.

View Article and Find Full Text PDF

Future Directions for Quantitative Systems Pharmacology.

Handb Exp Pharmacol

January 2025

Genentech Inc, South San Francisco, CA, USA.

In this chapter, we envision the future of Quantitative Systems Pharmacology (QSP) which integrates closely with emerging data and technologies including advanced analytics, novel experimental technologies, and diverse and larger datasets. Machine learning (ML) and Artificial Intelligence (AI) will increasingly help QSP modelers to find, prepare, integrate, and exploit larger and diverse datasets, as well as build, parameterize, and simulate models. We picture QSP models being applied during all stages of drug discovery and development: During the discovery stages, QSP models predict the early human experience of in silico compounds created by generative AI.

View Article and Find Full Text PDF

Optical metasurfaces, components composed of artificial nanostructures, are recognized for pushing boundaries of wavefront manipulation while maintaining a lightweight, compact design that surpasses conventional optics. Such advantages align with the current trends in optical systems, which demand compact communication devices and immersive holographic projectors, driving significant investment from the industry. Although interest in commercialization of optical metasurfaces has steadily grown since the initial breakthrough with diffraction-limited focusing, their practical applications have remained limited by challenges such as, massive-production yield, absence of standardized evaluation methods, and constrained design methodology.

View Article and Find Full Text PDF

High performance COVID-19 screening using machine learning.

Tunis Med

January 2025

Laboratory of viruses, vectors and hosts: LR20IPT10, Institut Pasteur de Tunis, University of Tunis El Manar, 13, Place Pasteur, 1002 Tunis Belvédère, Tunisia.

Since the World Health Organization declared the Coronavirus Disease 2019 (COVID-19) pandemic as an international concern of public health emergency in the early 2020, several strategies have been initiated in many countries to prevent healthcare services breakdown and collapse of healthcare structures. The most important strategy was the increased testing, diagnosis, isolation, contact tracing to identify, quarantine and test close contacts. In this context, finding a rapid, reliable and affordable tool for COVID-19 screening was the main challenge to address the pandemic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!